Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 10/25/2014 12:45:35 AM - Followers: 491 - Board type: Free - Posts Today: 8

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Current Report Filing (8-k) 10/24/2014 06:04:28 AM
CTIX News: ALTITRADE PARTNERS™ SAYS A KEY-REVERSAL DAY COULD HAPPEN THIS WEEK 10/14/2014 06:00:00 AM
CTIX News: Current Report Filing (8-k) 09/24/2014 03:48:22 PM
CTIX News: Annual Report (10-k) 09/15/2014 01:50:04 PM
CTIX News: Statement of Ownership (sc 13g) 09/04/2014 04:14:23 PM
News News Alert: Current Report Filing (8-k) 10/24/2014 06:04:28 AM
PostSubject
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#73082  Sticky Note Patrick Cox interviews Cellceutix Executives Dr. Menon & sox040713 10/09/14 04:20:59 PM
#69978  Sticky Note Cellceutix to President Obama: We Have The Tools CHM_760 09/19/14 07:22:18 AM
#69616  Sticky Note Based on the stock movement, I think that BioHedge 09/16/14 06:47:44 PM
#67831  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and KarinCA 09/03/14 06:13:02 PM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#75248   I didn't use a royalty; I used a BigKahuna 10/25/14 12:45:35 AM
#75247   If bottom line results are what we all BigKahuna 10/25/14 12:39:08 AM
#75246   CTIX Northern move just starting!!! BoilerRoom 10/25/14 12:37:51 AM
#75245   While I'm as much an animal lover as BigKahuna 10/25/14 12:36:43 AM
#75244   Yeah, my bad, but I also didn't account BigKahuna 10/25/14 12:27:33 AM
#75243   Sox, I agree that there is still some...surprise...waiting ROMAD Diver 10/25/14 12:27:29 AM
#75242   I beg to differ. Can you list tduggan 10/25/14 12:23:25 AM
#75241   I'll have what he's having. tduggan 10/25/14 12:14:34 AM
#75240   The numbers are mind boggling. Could this company scgmck1 10/24/14 11:37:23 PM
#75239   Your assuming royalties for all 3 B-indications? djs7 10/24/14 11:03:14 PM
#75238   Have you ever calculated the potential value of FarmaZutical 10/24/14 10:54:34 PM
#75237   $CTIX - daily. Chart looking strong, massive accumulation, Cheds 10/24/14 10:48:15 PM
#75236   As I read your post we would receive Tails 10/24/14 10:44:21 PM
#75235   Edge...you're a good man. Go CTIX! TheDane 10/24/14 10:39:23 PM
#75234   So using BK's 15% market penetration rate across monkeyplay1 10/24/14 10:38:30 PM
#75233   Way to go! And I'm delighted and humbled. etradeedge 10/24/14 10:02:15 PM
#75232   Called out BigKahuna's big miscalculation. As a monkeyplay1 10/24/14 09:43:24 PM
#75231   Big Kahuna, what % royalty did you use djs7 10/24/14 09:38:53 PM
#75230   No Whoops, as a retired dentist I can dougwur 10/24/14 09:34:53 PM
#75229   NR, what outcomes do you think will be Jhawker 10/24/14 09:20:33 PM
#75228   I don't know if that's true. govorchin 10/24/14 08:46:35 PM
#75227   With the success of B ABSSSI everything B Whoops 10/24/14 08:44:02 PM
#75226   It's great news. Very exciting. I want to Swish22 10/24/14 08:39:57 PM
#75225   If there is no other effective treatment for Whoops 10/24/14 08:37:57 PM
#75224   62 cents + BOD = NASDAQ up list .eom shenanigan 10/24/14 08:34:15 PM
#75223   Looking forward to a great news week next! alexwv 10/24/14 08:32:07 PM
#75222   This is a safe one that's for sure BoilerRoom 10/24/14 08:29:10 PM
#75221   Nice early call, timing wise and price..eom shenanigan 10/24/14 08:28:52 PM
#75220   It was cute, but don't take it literally, frrol 10/24/14 08:28:51 PM
#75219   I would think b-om won,t. Produce govorchin 10/24/14 08:28:34 PM
#75218   Frequently Asked Questions: Breakthrough Therapies Whoops 10/24/14 08:27:31 PM
#75217   This is literally the only security in my smitter 10/24/14 08:22:00 PM
#75216   Your crazy this is about to move go big!!!! BoilerRoom 10/24/14 08:19:01 PM
#75215   Love ya BK! smitter 10/24/14 08:17:53 PM
#75214   RIp Bioman! This is for you! smitter 10/24/14 08:15:39 PM
#75213   Yes that was a great sign! Awesome post! smitter 10/24/14 08:14:54 PM
#75212   Ask Big Kahuna on this board any questions smitter 10/24/14 08:10:10 PM
#75211   BK, I enjoy your shameless legitimate pumping by Whoops 10/24/14 07:58:02 PM
#75210   18 million patients a year for ABSSSI, 15% BigKahuna 10/24/14 07:54:59 PM
#75209   I'm glad someone picked that line up! alexwv 10/24/14 07:40:36 PM
#75208   Whoops, I am pretty sure Leo will share sox040713 10/24/14 07:27:25 PM
#75207   LoL Sox, when I read the topline results Whoops 10/24/14 07:17:46 PM
#75206   CTIX is up 141% from the 52 week sox040713 10/24/14 07:14:38 PM
#75205   Is it Monday yet? lol go CTIX tombrady12nh 10/24/14 07:02:20 PM
#75204   I have a feeling that Leo still has sox040713 10/24/14 07:00:48 PM
#75203   And since they killed dapto with 7 sae rosalieone 10/24/14 06:56:41 PM
#75202   Dear BK whats the market yearly for brillacidin? rosalieone 10/24/14 06:48:43 PM
#75201   welcome aboard Dr. Alexander... macnqueso 10/24/14 06:46:16 PM
#75200   respectfully disagree... Leo just needs to keep stacking macnqueso 10/24/14 06:43:10 PM
#75199   it really was a brilliant move... management took macnqueso 10/24/14 06:40:59 PM
PostSubject